Opinion statement
Treatment of nervous system Lyme disease depends on the severity and site of involvement. Although some data indicate that uncomplicated Lyme meningitis can be treated effectively with oral doxycycline, central nervous system infection (meningitis, radiculitis, encephalomyelitis, and cranial neuritis) is usually treated with parenteral antibiotics for 14 to 30 days, depending on disease severity, as is severe and progressive peripheral nervous system involvement. Ceftriaxone, 2 g/d, is the most commonly used regimen; cefotaxime, 2 g every 8 hours, appears to be equally effective. Penicillin in meningeal doses is also effective, perhaps slightly less so than the third-generation cephalosporins, but it is less convenient to administer. For patients with prohibitive drug allergies, treatment with oral doxycycline in doses of 300 to 400 mg/d may be effective. In patients with facial palsy or with indolent peripheral neuropathies, a trial of oral medication (doxycycline, 100 mg two or three times a day, or amoxicillin, 500 to 1000 mg three times a day for 21 to 30 days) is reasonable. Patients for whom this fails are treated with parenteral medications.
Similar content being viewed by others
References and Recommended Reading
Pediatric Lyme Disease Study Group: Lyme disease in children in southeastern Connecticut. N Engl J Med 1996, 335:1270–1274.
Luft BJ, Steinman CR, Neimark HC, et al.: Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992, 267:1364–1367.
Nichol G, Dennis DT, Steere AC, et al.: Test-treatment strategies for patients suspected of having Lyme. Ann Intern Med 1998, 128:37–48. Analysis of costs and benefits of testing for and treating Lyme disease in various settings.
Reid MC, Schoen RT, Evans J, et al.: The consequences of overdiagnosis and overtreatment of Lyme disease. Ann Intern Med 1998, 128:354–362.
Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ: Treatment of late Lyme disease. Lancet 1988, 1:1191–1193.
Dattwyler RJ, Luft BJ, Maladorno D, et al.: Treatment of late Lyme disease—a comparison of 2 weeks vs 4 weeks of ceftriaxone [abstract]. Proceedings of the Seventh International Congress on Lyme Borreliosis. San Francisco: International Congress on Lyme Borreliosis; 1996:186. This abstract describes a large multicenter, randomized trial demonstrating the efficacy of 2-week therapy.
Pfister HW, Preac MV, Wilske B, Einhaupl KM: Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis: a prospective randomized study. Arch Neurol 1989, 46:1190–1194.
Dattwyler RJ, Luft BJ, Kunkel MJ, et al.: Ceftriaxone compared with doxycycline for the treatment of acute Lyme disease. N Engl J Med 1997, 337:289–294.
Karlsson M, Hammers-Berggren S, Lindquist L, et al.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994, 44:1203–1207. Demonstrates the efficacy of oral doxycycline in Lyme meningitis.
Luger SW, Paparone P, Wormser GP, et al.: Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 1995, 39:661–667.
Luft BJ, Dattwyler RJ, Johnson RC, et al.: Azithromycin compared with amoxicillin in the treatment of erythema migrans. Ann Intern Med 1996, 124:785–791.
Sigal LH, Zahradnik JM, Lavin P, et al.: A vaccine consisting of recombinant Borrelia burgdorferi outer-surface. N Engl J Med 1998, 339:216–222.
Steere AC, Sikand VK, Meurice F, et al.: Vaccination against Lyme disease with recombinant Borrelia burgdorferi. N Engl J Med 1998, 339:209–215.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Halperin, J.J. Neuroborreliosis (nervous system lyme disease). Curr Treat Options Neurol 1, 139–145 (1999). https://doi.org/10.1007/s11940-999-0013-9
Issue Date:
DOI: https://doi.org/10.1007/s11940-999-0013-9